Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
889
datasets available to search
ShareScore release 0.9.0
Dataset results
889 results for “fatty liver”
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
ClinicalTrials.gov study NCT01679197. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT04031729. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2b Study of Icosabutate in Fatty Liver Disease
ClinicalTrials.gov study NCT04052516. IPD Sharing: NO. Countries: 2. Publications: 1.
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT05697991. IPD Sharing: NO. Countries: 1. Publications: 1.
Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease
ClinicalTrials.gov study NCT06664684. IPD Sharing: NO. Countries: 1. Publications: 6.
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06338449. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease
ClinicalTrials.gov study NCT05554224. IPD Sharing: YES. Countries: 1. Publications: 1.
Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT07294963. IPD Sharing: YES. Countries: 1. Publications: 4.
Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT03639623. IPD Sharing: NO. Countries: 1. Publications: 2.
2-Week Study In People With Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03513588. IPD Sharing: NO. Countries: 1. Publications: 1.
Insulin Resistance in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01289639. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06097039. IPD Sharing: NO. Countries: 1. Publications: 6.
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT02546609. IPD Sharing: NO. Countries: 1. Publications: 2.
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
ClinicalTrials.gov study NCT00586313. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
ClinicalTrials.gov study NCT03776175. IPD Sharing: YES. Countries: 1. Publications: 1.
Fatty Liver and Pancreatic Steatosis
ClinicalTrials.gov study NCT06757348. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
ClinicalTrials.gov study NCT02684591. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
ClinicalTrials.gov study NCT03061721. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT04073368. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01963845. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.